Trade Summary

1 week ago, Stueland Katherine, serving as CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 3,639 shares at $53.77 per share, for a total transaction value of $195,669.03. Following this transaction, Stueland Katherine now holds 96,123 shares of WGS.

This sale represents a 3.65% decrease in Stueland Katherine's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 4:11 PM ET, 2 days after the trade was made.

GeneDx Holdings Corp. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.